The business model is a brilliant one for a developmental Biotech. As Regen BioPharma generates revenue, I can see us performing Phase III as well and then licensing. Most of our treatments look like they'll be license out according to documentation.
The opinions, comments, or concerns, expressed herein, are solely that of the screen name 'd5wr59mfi8'. They are not to be misconstrued as legal or financial advice and should not be followed. For financial advice, please see the guidance of financial p